Perspectives on the draft ICH-M10 guidance: an interview with Eric J Woolf.

Area of Science:

• Analytical Chemistry
• Pharmacokinetics
• Bioanalysis

Background:

• Dr. Woolf holds a PhD in Analytical Chemistry and has extensive experience in drug metabolism and pharmacokinetics.
• He has been a key figure at Merck Research Laboratories since 1990, leading the regulated PK Bioanalysis Group.
• His career includes significant contributions to the development and registration of pharmaceutical compounds.

Discussion:

• The abstract highlights Dr. Woolf's extensive publication record in bioanalysis and pharmacokinetics.
• It emphasizes his group's role in supporting clinical development projects.
• The interview context points to engagement with regulatory guidelines like ICH-M10.

Key Insights:

• Dr. Woolf's leadership has been instrumental in advancing regulated bioanalysis within Merck.
• His research contributions have directly impacted the successful registration of Merck's drug candidates.
• Decades of experience underscore his expertise in bioanalytical sciences.

Outlook:

• Continued leadership in regulated bioanalysis is expected.
• Further contributions to drug development and regulatory science are anticipated.
• Engagement in industry workshops suggests an active role in shaping future bioanalytical standards.